NTII Projected Dividend Yield
Neurobiological Technologies, Inc. ( OTCBB : NTII )Neurobiological Technoligies has interest in an investigational drug called XERECEPT®, which is a synthetic preparation of Corticotropin-Releasing Factor, a natural human peptide. XERECEPT® is being developed by Celtic Pharma as a treatment for swelling around brain tumors and other cancer indications. Co. is entitled to receive payments for development and commercialization of XERECEPT by Celtic Pharma. 25 YEAR PERFORMANCE RESULTS |
|
NTII Dividend History Detail NTII Dividend News NTII Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |
